1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,042 | 0,044 | 12:01 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.03. | Cytophage Technologies Ltd: Cytophage forms committee to put itself on block | 6 | Stockwatch | ||
| 06.03. | Cytophage Technologies Ltd.: Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives | 2 | TheNewswire | ||
| 20.02. | Cytophage Technologies Ltd: Cytophage to cut work force at Cytophage Technologies | 1 | Stockwatch | ||
| 19.02. | Cytophage Technologies Ltd.: Cytophage Announces Operational Restructuring | 2 | TheNewswire | ||
| 20.01. | Cytophage Technologies Ltd: Cytophage appoints Kinley as CFO | 1 | Stockwatch | ||
| 20.01. | Cytophage names James Kinley as CFO | 2 | Seeking Alpha | ||
| 20.01. | Cytophage Technologies Ltd.: Cytophage Announces Appointment of James Kinley as Chief Financial Officer | 3 | TheNewswire | ||
| CYTOPHAGE TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 15.01. | Cytophage Technologies Ltd: Cytophage six-million-share private placement | 3 | Stockwatch | ||
| 29.11.25 | Cytophage Technologies Ltd: Cytophage completes $198,000 closing of placement | 3 | Stockwatch | ||
| 29.11.25 | Cytophage Technologies Ltd.: Cytophage Announces Closing of Non-Brokered Private Placement and Filing of Q3 Financials | 2 | TheNewswire | ||
| 13.11.25 | Cytophage Technologies Ltd.: Cytophage Announces Closing of First Tranche of Non-Brokered Private Placement | 3 | TheNewswire | ||
| 05.11.25 | Cytophage Technologies Ltd: Cytophage talks close of $1.2-million private placement | 2 | Stockwatch | ||
| 05.11.25 | Cytophage Technologies Ltd.: Cytophage Announces Closing Date of its Non-Brokered Private Placement | 1 | TheNewswire | ||
| 17.10.25 | Cytophage Technologies Ltd: Cytophage arranges $1.2-million private placement | 1 | Stockwatch | ||
| 17.10.25 | Cytophage Technologies Ltd.: Cytophage Announces Non-Brokered Private Placement | 1 | TheNewswire | ||
| 17.10.25 | Cytophage Technologies gibt nicht vermittelte Privatplatzierung bekannt | 500 | IR-WORLD | Winnipeg, den 17. Oktober 2025 / IRW-Press / Cytophage Technologies ("Cytophage" oder "das
Unternehmen") (TSXV:CYTO / FWB:70G), ein Biotechnologieunternehmen, das innovative Bakteriophagenlösungen... ► Artikel lesen | |
| 16.10.25 | Cytophage Technologies Ltd: Cytophage's OvaPhase to be distributed in Canada by WLT | 2 | Stockwatch | ||
| 16.10.25 | Cytophage Technologies startet die Kommerzialisierung von OvaPhage in Kanada in Zusammenarbeit mit W.L.T. Distributors | 494 | IR-WORLD | Winnipeg, den 16. Oktober 2025 - Cytophage Technologies ("Cytophage" oder "das Unternehmen") (TSXV:CYTO / FWB:70G), ein Biotechnologieunternehmen, das innovative Bakteriophagenlösungen für die... ► Artikel lesen | |
| 29.09.25 | Cytophage Technologies Ltd: Cytophage joins Canada's biomanufacturing mission in EU | 2 | Stockwatch | ||
| 29.09.25 | Cytophage Technologies Ltd.: Cytophage Receives Federal Support for Entry into European Market through France Biomanufacturing Mission | 3 | TheNewswire |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDIGENE | 0,029 | -13,61 % | Medigene: Zurückziehung - 18.11.2025 | ||
| CO.DON | 0,014 | -22,22 % | EQS-AFR: CO.DON AG i.l.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: CO.DON AG i.l.
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
CO.DON AG i.l.: Vorabbekanntmachung über die... ► Artikel lesen | |
| NUREXONE BIOLOGIC | 0,363 | -6,92 % | NurExone Biologic: ExoPTEN - realistische Perspektive zur Heilung von Nervenschäden | ||
| TME PHARMA | 0,063 | 0,00 % | TME Pharma NV: TME Pharma extends financial runway to over 12 months | TME Pharma extends financial runway to over 12 months Berlin, Germany, March 9, 2025, 08.00am CET - TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing... ► Artikel lesen | |
| REPLENISH NUTRIENTS | 0,077 | -3,25 % | Replenish Nutrients Closes Second Tranche of Private Placement Financing and Completes $1.95 Million Strategic Investment | ||
| MUSTGROW BIOLOGICS | 0,345 | 0,00 % | JETZT über 50 % KURSPOTENZIAL!? BioNTech, TUI und Bayer-Partner MustGrow | Lust auf ein Investment in einen Geheimtipp mit riesigem Marktpotenzial? Dann ist die Aktie von MustGrow interessant. Das Unternehmen wird mit unter 40 Mio. CAD bewertet. Die biologischen und regenerativen... ► Artikel lesen | |
| GLOW LIFETECH | 0,028 | -5,17 % | Glow Lifetech Corp.: Glow Lifetech Reduces Over 41 Million Warrants and 5 Million Options, Strengthening Capital Structure; All $0.05 Warrants Now Expired | Toronto, Ontario--(Newsfile Corp. - March 27, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce a significant reduction in its outstanding... ► Artikel lesen | |
| ADAPTIMMUNE THERAPEUTICS | 0,012 | 0,00 % | Adaptimmune Therapeutics PLC: Adaptimmune Announces Changes to Board and Executive Leadership Team | Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - November 17, 2025) - Adaptimmune Therapeutics plc (OTC Pink: ADAPY) ("Adaptimmune" or the "Company") today announced changes... ► Artikel lesen | |
| BIOVAXYS TECHNOLOGY | 0,043 | -1,15 % | BioVaxys Technology Corp.: BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda ) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer (EOC) | Study subject Remains in Complete Response for 3 YearsExceeds Expectations in Platinum-Resistant Ovarian Cancer Compared to Standard of Care Single-Agent ChemotherapyVancouver, British Columbia--(Newsfile... ► Artikel lesen | |
| TELO GENOMICS | 0,020 | 0,00 % | Telo Genomics Corp.: Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing | Vancouver, British Columbia--(Newsfile Corp. - March 9, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and... ► Artikel lesen | |
| ALTERITY THERAPEUTICS | 0,003 | -40,00 % | ALTERITY THERAPEUTICS LTD - 6-K, Report of foreign issuer | ||
| MEDMIRA | 0,032 | +14,29 % | MedMira, Inc.: MedMira Reports First Quarter Results FY2026 | HALIFAX, NOVA SCOTIA / ACCESS Newswire / December 30, 2025 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2025.Corporate updateIn Q1 FY2026... ► Artikel lesen | |
| GENETIC TECHNOLOGIES | 0,034 | -100,00 % | GENETIC TECHNOLOGIES LIMITED: Initial Director's Interest Notice - Campbell Welch | ||
| BIOPHYTIS | 0,020 | +0,50 % | Biophytis SA - 6-K, Report of foreign issuer | ||
| ACTIVE BIOTECH | 0,004 | +10,53 % | Active Biotech AB: Active Biotech Year End Report 2025 | FOURTH QUARTER IN BRIEFActive Biotech announced a fully secured rights issue, subject to approval by an extraordinary general meeting, of approximately SEK 70 million before transaction costs (October... ► Artikel lesen |
CYTOPHAGE TECHNOLOGIES LTD gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,035 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CYTOPHAGE TECHNOLOGIES LTD finden Sie auf Wallstreet Online.